According to the Ministry of Health and the National Emergency Commission (CNE), Costa Rica signed with AstraZeneca to supply one million doses of its candidate vaccine against COVID-19, AZD1222, developed together with the University of Oxford, QCOSTARICA reported on Friday.
The vaccine is expected to be available in the first quarter of 2021, if the clinical trials are successful and approval is given by regulatory agencies, at a price of $4 per dose.
Costa Rica now has agreements that would allow access to vaccines for just over three million people.
Costa Rica previously joined the COVAX-Facility mechanism, which provides for a population coverage of just over one million people, and has entered into an agreement with Pfizer and BioNTech for the immunisation of one and a half million individuals.
"This important advance in the task of preparing ourselves to vaccinate the population when vaccines are available is the result of the great work that the National Vaccine Commission has been developing and reflects our primary commitment to protect the health and life of citizens against the pandemic, using all the means at our disposal," said the President of the Republic Carlos Alvarado.
The deputy Minister of Health Pedro González explained that vaccination is expected to take place throughout 2021, without the plan yet being in place.
To read more NewsPoints articles, click here.